Gmail users: to ensure you're always viewing the entire newsletter, check at the bottom of the email to see if the newsletter has been "clipped" and click "view entire message" if so.
|
|
Moore Named Director of Breast Medical Oncology at Cleveland Clinic
|
The Case Comprehensive Cancer Center extends congratulations to
Halle Moore, MD, as earlier this week she was named director of breast medical oncology and co-director for the Comprehensive Breast Cancer Program at Cleveland Clinic. Dr. Moore joined Cleveland Clinic in 1999 and will assume her new role in January 2020. Her research involves the investigation of new treatments for breast cancer as well as the study of long-term effects of cancer treatment, including effects on fertility, bone health and cognitive function.
Five-year follow up results of a practice-changing study lead by Dr. Moore were published last year, demonstrating a method for protecting ovarian function during chemotherapy treatment for breast cancer in young women.
|
|
|
|
*NEW* Travel Scholarships to the 4th Annual Cancer Disparities Symposium
|
New this year, the Case Comprehensive Cancer Center Office of Cancer Disparities Research will award up to four travel scholarships to the symposium to promote professional development, diversity, and inclusivity among investigators and community organizations interested in cancer-related disparities research.
Travel scholarships include airfare, lodging, travel expenses, and a conference registration fee.
Applications must be submitted electronically by 5 pm ET on Tuesday, December 3, 2019.
|
|
Mon, Oct 28
Cancer Center Research Chalk Talk
Babal Jha, PhD
1p WRB 3-136
|
|
Tues, Oct 29
Immuno-Oncology Seminar Series
1p NE1-205
DNA Damage and Repair Working Group
3p WRB 1-422D
|
|
Thurs, Oct 31
D
evelopmental Therapeutics Journal Club
9a NE6-218
Immunology Journal Club
12p WRB 5-136
Molecular Biology and Microbiology Seminar
Carlin Lab
1p SOM W203
GU Center Endowed Chair Seminar
3p NE1-205
|
|
Fri, Nov 1
Taussig Cancer Institute Grand Rounds
Ashwin Kishtagari, MD
8a CA5-120
State of the School of Medicine
10a WRB Auditorium
Cancer Center
Special Seminar
Graham Warren, MD, PhD
12p WRB 2-136
Innovators in AYA Cancer Extended Abstract Deadline
|
|
|
Mon, Nov 4
Tumor Immunology and Immunotherapy Meeting
4p WRB 1-422D
|
|
Tues, Nov 5
NCRM Special Seminar
David Dean, PhD
12p WRB 3-136
Dale H. Cowan, MD-Ruth Goodman Blum Professorship Celebration
4:30p WRB
|
|
Weds, Nov 6
Cancer Microbiome Focus Group
12p See Invite for Location
|
|
Thurs, Nov 7
D
evelopmental Therapeutics Journal Club
9a NE6-218
Immunology Journal Club
Joshua Centore
12p WRB 5-136
Molecular Biology and Microbiology Seminar
Valadkhan Lab
1p SOM W203
|
|
Fri, Nov 8
Taussig Cancer Institute
Grand Rounds
Jaleh Fallah, MD
8a CA5-120
UH Seidman Cancer Center Grand Rounds
8a Wearn 137
Cancer Center Seminar Series
Johnie Rose, MD, PhD
12p WRB Auditorium
|
|
|
 |
Cancer Center Seminar Series
October 25, 12p
WRB Auditorium
Today at noon, our seminar will return to the WRB Auditorium and feature Alok Khorana, MD presenting, "Cancer-Associated Thrombosis: Mechanisms, Prevention and Treatment.
"
Alok Khorana is Vice-Chair, Clinical Services at Taussig Cancer Institute, Director of the GI Malignancies Program, and professor of medicine at the Lerner College of Medicine, Cleveland Clinic. Dr. Khorana is also a member of the
Case CCC's Developmental Therapeutics Program.
His clinical and translational research program focuses on predictive factors and drug development in cancer-associated thrombosis and gastrointestinal cancers.
|
|
|
|
Cancer Center Special Seminar
November 1, 12p
WRB 2-136
Please join us Friday, November 1 in the Wolstein Research Building Conference Room 2-136 to hear from
Graham W. Warren, MD, PhD. Dr. Warren is professor and Vice Chairman for Research in Radiation Oncology, departments of Radiation Oncology, Cell and Molecular Pharmacology and Experimental Therapeutics at Hollings Cancer Center, part of the Medical University of South Carolina. He will present, "Improving the Effectiveness of Cancer Treatment by Addressing Tobacco Use."
|
|
|
|
|
NCRM Special Seminar
November 5, 12p
WRB 3-136
The
National Center for Regenerative Medicine (NCRM) is hosting a special seminar on Tuesday, November 5 at 12p in WRB conference room 3-136 featuring
David Dean, PhD.
Dr. Dean is associate professor of plastic surgery at The Ohio State University and Member of The Center for Regenerative Medicine and Cell-Based Therapies.
Dr. Dean's research has led to the development of computer-aided design software for the additive manufacture, also referred to as 3D printing, of tissue-engineered bone implants. His research program currently includes the seeding of bone marrow-derived mesenchymal stem cells in 3D printed bone tissue engineering scaffolds. These scaffolds are bioreactor pre-cultured prior to implantation. Much of this research has focused on the repair of critical size and larger cranial defects.
|
|
|
|
Dale H. Cowan, MD-Ruth Goodman Blum Cancer Research Professorship Program and Reception
November 5, 4:30p
Wolstein Research Building
|
A program and reception celebrating the appointment of Zhenghe John Wang, PhD as the Dale H. Cowan, MD-Ruth Goodman Blum Professor of Cancer Research will be held on Tuesday, November 5 at 4:30 pm in the Wolstein Research Building.
Complementary valet parking will be available on Circle drive between Mayfield and Cornell Roads.
Please RSVP to Barbara Nicol Waltermire by Tuesday, October 29, 2019 if you wish to attend.
|
|
|
|
|
Innovators in AYA Cancer Symposium
November 14-15, 2019
Tinkham Veale University Center
The Angie Fowler Adolescent and Young Adult (AYA) Cancer Research Initiative of the Case Comprehensive Cancer Center invites you to attend Innovators in AYA Cancer: Driving Science and Policy toward a Brighter Future for Teens and Young Adults with Cancer this November at Case Western Reserve University. The symposium will feature expert talks researchers, patients and survivors on sarcoma, immunotherapy, clinical trials, policy and survivorship.
Call for Abstracts Deadline Extended
The Symposium will feature a poster session and Rising Star oral presentations. All students, postdocs, residents, fellows and faculty conducting research in AYA cancer are invited to submit abstracts. Monetary prizes will be awarded.
Abstracts must be submitted electronically by Friday, November 1, 2019 at 5pm ET.
Learn more>
Register today to save your seat! A discount for students and trainees who wish to attend is available. We look forward to seeing you in November!
|
|
|
|
2019 Clinical Research Retreat
November 21, 5-7p
Taussig Cancer Center CA5-120
The Case Comprehensive Cancer Center will host the Clinical Research Retreat, a semi-annual showcase of clinical cancer research across our institutions from 5-7 pm on Thursday, November 21 at Cleveland Clinic Taussig Cancer Institute, CA5-120.
The evening's agenda is focused on two timely and exciting areas of cancer clinical research. First, attendees will hear from current NCI K12 Paul Calabresi Scholars, Molly Gallogly, Roberto Vargas, Kristen VanHeyst and Haider Mahdi who will discuss their innovative investigator initiated treatment (IIT) protocol that is based on preclinical models. Since development of an exciting IIT protocol takes a village, your feedback will be important.
Secondly,
Charles Kunos, MD, PhD, a clinical investigator and protocol reviewer at CTEP, NCI will deliver his keynote address, "Engaging CTEP in early phase radiopharmaceutical trials" updating us on innovative approaches to evaluate this drug class. Dr. Kunos is a graduate of our long-standing K12 program and was a member of the
Case CCC before moving on to the NCI.
Validated parking is available at 2101 East 100th St, Cleveland, OH 44106.
|
|
|
|
|
4th Annual Cancer Disparities Symposium
March 6, 2020
Tinkham Veale University Center
The Case Comprehensive Cancer Center Office of Cancer Disparities Research will present the
4th Annual Cancer Disparities Symposium
:
Cultivating Science and Community Engagement to Address Cancer Health Disparities on March 6, 2020.
The symposium will feature keynote presentations by renowned disparities researchers and community leaders, a poster session highlighting academic research and community programs, networking opportunities and an interactive panel discussion.
Call for Abstracts
The
4th Annual Cancer Disparities Symposium
is a premier event for presenting cutting-edge cancer disparities science and related community programs and services. The Office of Cancer Disparities Research will divide abstracts into two tracks:
Scientific Research
and
Community Programs and Services
. Scientific Research abstracts are encouraged from multidisciplinary researchers that are focused on various aspects of health disparities and/or community-focused science. Community programs and service abstracts are encouraged from organizations that provide programs and services that benefit the community. Meritorious abstracts will be selected for oral presentation.
Abstracts must be submitted electronically by 5p EST on Tuesday, December 3, 2019.
Students who submit an abstract prior to registration are able to register for free!
Learn more>
|
|
|
|
Additional Upcoming Events
|
|
|
Cleveland Clinic Best of Radiation Oncology 2019
November 9, 2019
Independence, OH
|
|
|
|
Cleveland Clinic Breast Cancer Update: From Detection Through Treatment to Survivorship
November 13, 2019
Independence, OH
|
|
|
|
|
Cleveland Clinic Children's Pediatric Lecture Series
November 25, 8a
Cleveland Clinic R3-002/003
|
Join Cleveland Clinic Children's for "The Science of Pediatric Blood & Cancer" Lecture Series featuring
Gregory H. Reaman, MD presenting, "Pediatric Cancer Drug Development: The Road Well Traveled by the Therapeutic Orphans - Construction Ahead."
|
|
|
|
NCCN 2020 Annual Conference
March 20-22, 2020
Orlando, FL
|
Abstract submission for the General Poster Session is open through Wednesday, October 23, 2019.
|
|
|
|
Deadlines: December 6 & December 13, 2019
The Pancreatic Cancer Action Network has released two funding opportunities for 2020. Each award supports investigators for two years.
The Translational Research Grant ($500,000) supports an independent investigator conducting high priority pancreatic cancer research that is poised for important translational next steps to help move scientific discovery to application in patients. Proposed research should aim to identify novel targets and approaches to the treatment of pancreatic cancer or understand and circumvent treatment resistance.
The Career Development Award ($200,000) Supports junior faculty to conduct pancreatic cancer research and establish successful career paths in the field. Proposed research may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer.
|
|
Deadline: January 7, 2020
The Physician Scientist Fellowship (PSF) award aims to support research during final years of subspecialty fellowship and aid in the transition into an academic faculty appointment. The Doris Duke Charitable Foundation has released a request for applications for grants of up to $220,000 over two years to be awarded to physician scientists (MD, MD/PhD, DO or foreign equivalent) in subspecialty fellowship training working at US medical institutions to support two years of clinical research that will strengthen their careers as biomedical investigators.
|
|
Open Funding Opportunities at the Case Comprehensive Cancer Center
Deadlines Vary
Deadline: Friday, Nov 8, 2019
Deadline: Friday, Nov 8, 2019
Deadline: Friday, Nov 8, 2019
LOI Deadline: November 18
View previously announced funding opportunities for additional awards and application criteria.
|
|
Deadline: March 18, 2020
The Howard Hughes Medical Institute (HHMI) is seeking to appoint approximately 20 new Investigators through a national open competition. This effort will expand HHMI’s community of nearly 300 Investigators, who perform basic biological research across the nation.
The HHMI Investigator competition is open to basic researchers and physician scientists from more than 200 eligible institutions who catalyze discovery research in basic and biomedical sciences, plant biology, evolutionary biology, biophysics, chemical biology, biomedical engineering, and computational biology.
HHMI Investigators receive a seven-year appointment, which is renewable pending favorable scientific review. HHMI encourages Investigators to push their research fields into new areas of inquiry.
|
|
Health Tech Magazine Daily - Oct 8, 2019
“They are using AI to find things like lymph node metastases,” says
Anant Madabhushi, PhD, director of the Center for Computational Imaging and Personalized Diagnostics at CWRU and member,
Case CCC. “These things are challenging and AI can play a role in alleviating that challenge.”
|
|
KTVA - Oct 18, 2019
"This is really going to cost lives if we don't act as a nation to solve this problem," says
Rabi Hanna, MD, chair of pediatric hematology-oncology at Cleveland Clinic and member,
Case CCC.
|
|
Weekly NIH Funding Opportunities and Notices
|
Notices
Funding Opportunities
|
|
Use the button below to submit all your news, events, announcements and communications requests to the Case CCC Marketing and Communications team!
|
|
|
|
|
|
|
